Enveric Biosciences Inc vs KraneShares CSI China Internet ETF — how do they compare? Enveric Biosciences Inc trades at $1.4 (market cap $5.32M), while KraneShares CSI China Internet ETF trades at $27.52. The key difference: KraneShares CSI China Internet ETF is trading nearer its 52-week high, Enveric Biosciences Inc nearer its low. Which is the better fit depends on your goals.
| ENVB | KWEB | |
|---|---|---|
Market Cap | $5.32M | — |
Sector | Health | Sector/Thematic |
52-Week High | $17.40 | $42.94 |
52-Week Low | $1.28 | $23.63 |
Enterprise Value | $408.82K | — |
Signals from Pluang's Aura AI — not financial advice
ENVB trades at $1.38, up 4.55% today, with a bearish technical signal from moving averages but neutral oscillators. The company reported a net loss of $8.77M for 2025, though it beat EPS estimates in all four quarters. Recent news highlights participation in investor conferences and progress with its neuroplastogen candidate EB-003, including IND-enabling studies and positive preclinical results.
Outlook hinges on clinical progress, with 75% analyst buy ratings supporting potential upside, but high financial losses and negative ROE/ROA pose significant risks. Investors face volatility from regulatory developments and funding needs, making it speculative despite positive sentiment from recent operational updates.
KWEB, the KraneShares CSI China Internet ETF, gained 5.02% to $27.495, showing strong bullish momentum with technical indicators signaling buy sentiment. The ETF tracks Chinese internet and AI companies benefiting from government support and AI-driven growth. Recent news highlights China's $295 billion AI infrastructure plan and strong export performance, particularly in AI hardware, driving manufacturing recovery.
While KWEB offers exposure to undervalued Chinese tech giants with AI catalysts, risks include US-China tensions and regulatory uncertainties. The ETF trades near 52-week lows, presenting potential value, but geopolitical factors and leveraged competitor funds like YINN pose volatility risks for investors seeking China internet exposure.
Trailing returns across standard periods
Latest headlines on both assets
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →KWEB tracks the CSI Overseas China Internet Index, providing exposure to Chinese software and services companies listed in the US and Hong Kong, including giants like Tencent, Alibaba, and Meituan.
Read more on KWEB →